FLAG with Bortezomib in Childhood Relapsed Refractory Leukaemia- A Single Centre Experience
Sreedhar Jayakrishnan, MD1*, Kesavan MR, MD, FNB (Paediatric Hemato Oncology) 2, Gangadharan KV MD, DM(Medical Oncology). 1, Sreelesh KP MD, DM (Medical Oncology)1, Arun Chandrashekaran MD, DM (Medical Oncology) 1, Sudeep Vaniyath MD, DM (Clinical Haematology) 3, Karthika KV MD, DM (Hematopathology)4,
1 Department of Medical Oncology, ASTER MIMS, Kozhikode, India
2 Department of Pediatric Hematology and Hemato-Oncology, ASTER MIMS, Kozhikode, India
3 Department of Hematology and Hemato-Oncology, ASTER MIMS, Kozhikode, India
4 Department of Pathology, ASTER MIMS, Kozhikode, India
* Correspondence to:
Sreedhar Jayakrishnan, MD, Department of Medical Oncology, ASTER MIMS, Kozhikode, Kerala, India , 673016
Tel.: +91-8495819063, Email: srj1216353@gmail.com
Running Title- FLAG-Bortezomib in Paediatric relapsed/refractory Leukaemia
Number of Tables- One
Key Words- Haematology, Haemato- Oncology, Relapsed Leukaemia, Toxicity, Hematopoietic Stem Cell Transplant
Word Count-
1280 Words (Main Text)
106 (Abstract)